Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.05 B JPY
305.62 M JPY
20.22 M
About PRISM BIOLAB CO LTD
Sector
Industry
CEO
Dai Takehara
Website
Headquarters
Fujisawa
Founded
2006
ISIN
JP3833190006
FIGI
BBG01N2DL673
PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 206A is 285 JPY — it has increased by 0.71% in the past 24 hours. Watch PRISM BIOLAB CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange PRISM BIOLAB CO LTD stocks are traded under the ticker 206A.
206A stock has fallen by −2.07% compared to the previous week, the month change is a −14.97% fall, over the last year PRISM BIOLAB CO LTD has showed a −41.72% decrease.
206A reached its all-time high on Jul 10, 2024 with the price of 672 JPY, and its all-time low was 285 JPY and was reached on Dec 19, 2024. View more price dynamics on 206A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
206A stock is 2.49% volatile and has beta coefficient of 0.73. Track PRISM BIOLAB CO LTD stock price on the chart and check out the list of the most volatile stocks — is PRISM BIOLAB CO LTD there?
Yes, you can track PRISM BIOLAB CO LTD financials in yearly and quarterly reports right on TradingView.
PRISM BIOLAB CO LTD is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
206A net income for the last quarter is −479.97 M JPY, while the quarter before that showed −233.49 M JPY of net income which accounts for −105.56% change. Track more PRISM BIOLAB CO LTD financial stats to get the full picture.
No, 206A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 206A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PRISM BIOLAB CO LTD stock right from TradingView charts — choose your broker and connect to your account.